Article Versions Notes

Alserawan L, Anguera G, Zamora Atenza C, Serra López J, Martínez-Martínez L, Riudavets Melià M, Sullivan I, Barba Joaquin A, Majem Tarruella M, Vidal S. Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events. International Journal of Molecular Sciences. 2022; 23(20):12641. https://doi.org/10.3390/ijms232012641

Alserawan, Leticia, Geòrgia Anguera, Carlos Zamora Atenza, Jorgina Serra López, Laura Martínez-Martínez, Mariona Riudavets Melià, Ivana Sullivan, Andrés Barba Joaquin, Margarita Majem Tarruella, and Silvia Vidal. 2022. "Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events" International Journal of Molecular Sciences 23, no. 20: 12641. https://doi.org/10.3390/ijms232012641

Alserawan, L., Anguera, G., Zamora Atenza, C., Serra López, J., Martínez-Martínez, L., Riudavets Melià, M., Sullivan, I., Barba Joaquin, A., Majem Tarruella, M., & Vidal, S. (2022). Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events. International Journal of Molecular Sciences, 23(20), 12641. https://doi.org/10.3390/ijms232012641